No Data
No Data
Scilex Holding Says U.S. Bankruptcy Court Extended Lockup Period on Shares Previously Distributed by Sorrento to Its Stockholders as a Dividend >SCLX
Scilex Holding Says U.S. Bankruptcy Court Extended Lockup Period on Shares Previously Distributed by Sorrento to Its Stockholders as a Dividend >SCLX
Scilex Holding Ends Equity Purchase Deal With Yorkville
Scilex Holding Co And Ya II PN Mutually Agreed To Terminate Amended And Restated Standby Equity Purchase Agreement, Dated As Of Feb 8, 2023
Scilex Holding Co And Ya II PN Mutually Agreed To Terminate Amended And Restated Standby Equity Purchase Agreement, Dated As Of Feb 8, 2023
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
Scilex has been working with its co-pay savings card adjudicators to resolve the recent breakdown of processing of insurance claims by Change Healthcare, following a cyber-attack on Change Healthcare.
Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label
Scilex Holding (SCLX) said Wednesday it plans to seek approval from the US Food and Drug Administration to change the label of gout drug Gloperba to add dosing guidance for people with renal impairmen
Scilex Holding To Seek Approval Fro MFDA For Modification Of Gloperba To Include
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for t
No Data